LabCompass

M.H. Cho

Medicine · Purdue University West Lafayette

Mid career · publishing since 2002Rising activity

Publications

56

Citations

156

Est. group size

~3

Recurring co-author estimate

Active years

24

Publishing since 2002

Research summary
AI-generated

This research profile centers on chronic obstructive pulmonary disease (COPD) and related lung diseases, using imaging, genetics, and biomarkers to understand disease progression and predict outcomes like exacerbations and mortality. Work includes analyzing airway mucus plugging on CT scans, genetic risk scores, and proteomic markers in large patient cohorts such as COPDGene. Note: several unrelated publications on control systems engineering (e.g., multi-agent systems, cyberattack resilience) appear in this record, suggesting possible name overlap with another author rather than a single unified research program.

COPD diagnosis and progressionLung imaging biomarkers (airway mucus, CT)Genetics and genomics of lung diseaseInterstitial lung disease and fibrosisProteomic and epigenetic biomarkers

Publication output has grown substantially over the past decade, rising from near zero in 2017-2019 to a steady high output of 10-13 papers per year in 2023-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 8.6/year recently
172018: 2 publications182019: 1 publication192020: 5 publications202021: 3 publications212022: 7 publications222023: 10 publications232024: 13 publications13242025: 13 publications132526
Recent publications
Publishes in
  • American Journal of Respiratory and Critical Care Medicine×7
  • IEEE Control Systems Letters×3
  • arXiv (Cornell University)×2
  • Nature Communications×1
  • EBioMedicine×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile